Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis

Peritoneal dialysis (PD) is a form of renal replacement treatment, which employs the peritoneal membrane (PM) to eliminate toxins that cannot be removed by the kidney. The procedure itself, however, contributes to the loss of the PM ultrafiltration capacity (UFC), leading consequently to the techniq...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Liappas, Georgios, González-Mateo, Guadalupe, Aguirre, Anna Rita, Abensur, Hugo, Albar-Vizcaino, Patricia, Parra, Emilio González, Sandoval, Pilar, Ramírez, Laura García, del Peso, Gloria, Acedo, Juan Manuel, Bajo, María A., Selgas, Rafael, Tomero, José A. Sánchez, López-Cabrera, Manuel, Aguilera, Abelardo
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2016
主題:
Research Paper: Pathology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058669/
https://ncbi.nlm.nih.gov/pubmed/27102153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8780
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料